2012 annual financial data

Capricor Therapeutics, Inc. 2012 Net margin

Capricor Therapeutics, Inc. 2012 net margin with verified reported values.

Direct answer

Net margin was -968.29%.

Operating income was -2,440,000 USD and net income was -1,893,000 USD.
Operating cash flow was -2,186,681 USD.

Get free Capricor Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
195,500 USD
Operating income
-2,440,000 USD
Net income
-1,893,000 USD
Operating cash flow
-2,186,681 USD